244 related articles for article (PubMed ID: 16384627)
1. Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales.
Sutton AJ; Gay NJ; Edmunds WJ
Vaccine; 2006 Mar; 24(13):2377-86. PubMed ID: 16384627
[TBL] [Abstract][Full Text] [Related]
2. Modelling the hepatitis B vaccination programme in prisons.
Sutton AJ; Gay NJ; Edmunds WJ; Andrews NJ; Hope VD; Gilbert RL; Piper M; Gill ON
Epidemiol Infect; 2006 Apr; 134(2):231-42. PubMed ID: 16490125
[TBL] [Abstract][Full Text] [Related]
3. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
[TBL] [Abstract][Full Text] [Related]
4. Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccine programme in prisons.
Hutchinson SJ; Wadd S; Taylor A; Bird SM; Mitchell A; Morrison DS; Ahmed S; Goldberg DJ
Vaccine; 2004 Nov; 23(2):210-4. PubMed ID: 15531039
[TBL] [Abstract][Full Text] [Related]
5. Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales?
Judd A; Hickman M; Hope VD; Sutton AJ; Stimson GV; Ramsay ME; Gill ON; Parry JV
J Viral Hepat; 2007 Aug; 14(8):584-91. PubMed ID: 17650293
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B vaccine uptake among injecting drug users in England 1998 to 2004: is the prison vaccination programme driving recent improvements?
Hope VD; Ncube F; Hickman M; Judd A; Parry JV
J Viral Hepat; 2007 Sep; 14(9):653-60. PubMed ID: 17697018
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B vaccination coverage and uptake in prisons across England and Wales 2003-2010: a retrospective ecological study.
Beck CR; Cloke R; O'Moore É; Puleston R
Vaccine; 2012 Mar; 30(11):1965-71. PubMed ID: 22265944
[TBL] [Abstract][Full Text] [Related]
8. Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy.
Hahné S; Ramsay M; Balogun K; Edmunds WJ; Mortimer P
J Clin Virol; 2004 Apr; 29(4):211-20. PubMed ID: 15018847
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus among injecting drug users in Sydney, Australia: prevalence, vaccination and knowledge of status.
Day CA; White B; Dore GJ; van Beek I; Rodgers C; Cunningham P; Wodak A; Maher L
Drug Alcohol Depend; 2010 Apr; 108(1-2):134-7. PubMed ID: 20047803
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of hepatitis B, tetanus, hepatitis A, human immunodeficiency virus and feasibility of vaccine delivery among injecting drug users in Bangkok, Thailand, 2003-2005.
Sunthornchart S; Linkins RW; Natephisarnwanish V; Levine WC; Maneesinthu K; Lolekha R; Tappero JW; Trirat N; Muktier S; Chancharastong P; Fox K; Donchalermpak S; Vitek C; Supawitkul S
Addiction; 2008 Oct; 103(10):1687-95. PubMed ID: 18705685
[TBL] [Abstract][Full Text] [Related]
11. Predictors of hepatitis B vaccination in women prisoners in two prisons in England.
Plugge EH; Yudkin PL; Douglas N
J Public Health (Oxf); 2007 Dec; 29(4):429-33. PubMed ID: 17878212
[TBL] [Abstract][Full Text] [Related]
12. Modelling alternative strategies for delivering hepatitis B vaccine in prisons: the impact on the vaccination coverage of the injecting drug user population.
Sutton AJ; Gay NJ; Edmunds WJ; Gill ON
Epidemiol Infect; 2008 Dec; 136(12):1644-9. PubMed ID: 18346286
[TBL] [Abstract][Full Text] [Related]
13. Increasing hepatitis B vaccine coverage in prisons in England and Wales.
Gilbert RL; Costella A; Piper M; Gill ON
Commun Dis Public Health; 2004 Dec; 7(4):306-11. PubMed ID: 15779795
[TBL] [Abstract][Full Text] [Related]
14. [Offer hepatitis B vaccination to the addicts. Transmission of hepatitis B among intravenous drug abusers].
Struve J; Käll K; Oksanen A; Stendahl P
Lakartidningen; 1993 Jun; 90(23):2225-7. PubMed ID: 8502085
[TBL] [Abstract][Full Text] [Related]
15. Impact of a targeted hepatitis B vaccination program in Amsterdam, The Netherlands.
van Houdt R; Sonder GJ; Dukers NH; Bovee LP; van den Hoek A; Coutinho RA; Bruisten SM
Vaccine; 2007 Mar; 25(14):2698-705. PubMed ID: 16919856
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus exposure and vaccination in a cohort of people who inject drugs: what has been the impact of targeted free vaccination?
Winter RJ; Dietze PM; Gouillou M; Hellard ME; Robinson P; Aitken CK
J Gastroenterol Hepatol; 2013 Feb; 28(2):314-22. PubMed ID: 23190264
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B vaccination in prisons.
Awofeso N
Bull World Health Organ; 2002; 80(7):569-74. PubMed ID: 12163921
[TBL] [Abstract][Full Text] [Related]
18. Poor criterion validity of self-reported hepatitis B infection and vaccination status among injecting drug users: a review.
Topp L; Day C; Dore GJ; Maher L
Drug Alcohol Rev; 2009 Nov; 28(6):669-75. PubMed ID: 19930022
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology of hepatitis B virus infections in Denmark.
Fisker N; Pedersen C; Lange M; Nguyen NT; Nguyen KT; Georgsen J; Christensen PB
J Clin Virol; 2004 Sep; 31(1):46-52. PubMed ID: 15288613
[TBL] [Abstract][Full Text] [Related]
20. A comparison between the force of infection estimates for blood-borne viruses in injecting drug user populations across the European Union: a modelling study.
Sutton AJ; Hope VD; Mathei C; Mravcik V; Sebakova H; Vallejo F; Suligoi B; Brugal MT; Ncube F; Wiessing L; Kretzschmar M
J Viral Hepat; 2008 Nov; 15(11):809-16. PubMed ID: 18761605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
